spirapril

Uses your system voice; voice and rate in settings.

Q835757Snapshot

≈ 1 min read

Names in other languages

  • Englishspirapril
  • Françaisspirapril
  • Magyarspirapril
  • ItalianoSpirapril
  • Nederlandsspirapril
  • Polskispirapryl
  • Portuguêsspirapril
  • СрпскиSpirapril

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Spirapril, sold under the brand name Renormax among others, is an ACE inhibitor antihypertensive drug used to treat hypertension. It belongs to dicarboxy group of ACE inhibitors. It was patented in 1980 and approved for medical use in 1995.

Spirapril, sold under the brand name Renormax among others, is an ACE inhibitor antihypertensive drug used to treat hypertension. It belongs to dicarboxy group of ACE inhibitors. It was patented in 1980 and approved for medical use in 1995.

Chemistry

Like many ACE inhibitors, this prodrug is converted to the active metabolite spiraprilat following oral administration. Unlike other members of the group, it is eliminated both by renal and hepatic routes, which may allow for greater use in patients with renal impairment. However, data on its effect upon the renal function are conflicting.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1332222518 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.